EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Clinical trial NCT06375928 · UNKNOWN

Trial details

NCT number: NCT06375928
Sponsor: Hospital Universitari de Bellvitge
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Malignant Biliary Obstruction Pancreatic Cancer Resectable Biliary Tract Neoplasms

Start date: 2024-05-01
Primary completion: 2026-02-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.